Loading clinical trials...
Loading clinical trials...
A Pilot Study of the PI3K Inhibitor BKM120 in Patients With Relapsed Lymphoma
Conditions
Interventions
Buparlisib
Laboratory Biomarker Analysis
+1 more
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
December 1, 2012
Primary Completion Date
September 16, 2016
Completion Date
March 22, 2017
Last Updated
October 9, 2018
NCT04054167
NCT06839053
NCT06859008
NCT02153580
NCT01815749
NCT03015896
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions